Clonexpress, Inc.

clonexpress has developed a novel technology platform to generate patient-specific differentiated cell types by epigenetic induction. clonexpress has developed patient specific pancreatic beta cells, hepatocytes, and dopaminergic neuron cells from adult human fibroblasts and peripheral blood mononuclear cells (three issued patents- us9,029,141b2,us9,394,525 and us10,100,280b2). clonexpress has developed human pancreatic beta islets cell line (glucose responsive insulin release similar to primary beta cells) and hepatocyte (metabolism qualified ) cell lines. these cell lines are very close to normal cells and are available for licensing or purchase for drug discovery and toxicology applications. clonexpress has recently developed a human microglial cell line available for licensing or purchase. custom development of tumor cell lines from tumor samples provided by the client -successfully developed multiple myeloma and other cell types from tumor samples provided by clients custom cell line development of cell lines using primary cells provided by client (both human and non-human) for research use. clonexpres has discovered a common growth control mechanism in different types of cancers, and such growth control mechanism is not present in different normal cells (fibroblasts and mesenchymal cells) capable of continuous growth in culture. this is a totally new paradigm to develop new class of drugs with minimal or no side effects to cure cancer and metastasis. clonexpress has developed a very sensitive assay to identify the target. clonexpress is actively seeking funding /partnership opportunities to use this technology to find a cure for different types of cancer. clonexpress also provides human central nervous system (cns) primary cells - neuronal progenitor cells, dopaminnergic neuron cells, astrocytes, and microglial cells, diffetrent endothelial cells, human fibroblasts, bone marrow stromal cells, liver mesenchymal cells to for research.

Probeer het snel met tomba.io.

Feiten over Clonexpress, Inc.

Website

clonexpress.com

Gesticht

1992

Aantal werknemers

1-10

Industrie

biotechnology

Land

US

Staat

Maryland

Stad

Gaithersburg

Adres

504 E Diamond Ave

Telefoonnummer

(301) 869-0840

Email pattern

{last}{f}

Email Accept all Toestand

False

Email Blocked Toestand

False

Whois Aanmaakdatum

May 5th 1999, 05:00:31 pm

RWhois

networksolutions.c...

Whois Name

Network Solutions, LLC

Total Emails

2

Total Personal Emails

1

Total Generic Emails

1

Last updated

July 26th 2023, 11:37:58 pm

Znajdź adres e-mail osoby stojącej za dowolną witryną internetową

Sociale accounts van Clonexpress, Inc.

Onbekend

Onbekend

Alle e-mailadressen voor clonexpress.com

thiru gopal

t***@clonexpress.com
We konden dit e-mailadres niet openbaar beschikbaar vinden op internet.

regional vice president

0 Sources

-8 meer voor uw zoekopdracht clonexpress.com

Maak een account aan om de e-mailadressen te ontdekken, de volledige resultaten te krijgen, zoekfilters, CSV-downloads en meer.

E-mailformaat

EmailPattern #

johndoe@clonexpress.com

{first}{last}

No

john.doe@clonexpress.com

{first}.{last}

No

john-doe@clonexpress.com

{first}-{last}

No

doejohn@clonexpress.com

{last}{first}

No

doe.john@clonexpress.com

{last}.{first}

No

doe-john@clonexpress.com

{last}-{first}

No

jdoe@clonexpress.com

{f}{last}

No

j.doe@clonexpress.com

{f}.{last}

No

j-doe@clonexpress.com

{f}-{last}

No

johnd@clonexpress.com

{first}{l}

No

john.d@clonexpress.com

{first}.{l}

No

john-d@clonexpress.com

{first}-{l}

No

djohn@clonexpress.com

{l}{first}

No

d.john@clonexpress.com

{l}.{first}

No

d-john@clonexpress.com

{l}-{first}

No

doej@clonexpress.com

{last}{f}

Available

doe.j@clonexpress.com

{last}.{f}

No

doe-j@clonexpress.com

{last}-{f}

No

john@clonexpress.com

{first}

No

doe@clonexpress.com

{last}

No

jd@clonexpress.com

{f}{l}

No

j.d@clonexpress.com

{f}.{l}

No

j-d@clonexpress.com

{f}-{l}

No

dj@clonexpress.com

{l}{f}

No

d.j@clonexpress.com

{l}.{f}

No

d-j@clonexpress.com

{l}-{f}

No

Veel voorkomende vragen over Clonexpress, Inc.

Where is Clonexpress, Inc.'s physical location?

Clonexpress, Inc. is headquartered in US.

Can you detail the whois information for Clonexpress, Inc.'s domain?

Clonexpress, Inc.'s domain whois information was last updated on 1999-05-05T19:00:31+02:00, The registrant name associated with the domain is Network Solutions, LLC.

What are the key industries and company size for Clonexpress, Inc.?

Clonexpress, Inc. operates within the biotechnology industry and reports a company size of 1-10 employees.

Can you provide Clonexpress, Inc.'s contact information?

Certainly, Clonexpress, Inc. can be reached at the phone number (301) 869-0840.

What is the total number of emails cataloged by Clonexpress, Inc.?

As of the latest update, Clonexpress, Inc. has cataloged a total of 2 emails.

Does Clonexpress, Inc. have any restrictions on the types of emails it accepts?

Clonexpress, Inc. does not indiscriminately accept all types of emails. The platform has specific criteria and verification processes to ensure the validity and relevance of the email addresses it lists, reflecting its policy on accepting specific types of emails.

Is there any block on Clonexpress, Inc.'s email finding capabilities?

No, there is no block on Clonexpress, Inc.'s email finding capabilities, confirming that the service operates freely without no restrictions.

How can one connect with Clonexpress, Inc. on social media?

Clonexpress, Inc. maintains an active presence on major social media platforms, including Twitter (undefined), Facebook (undefined), and LinkedIn (clonexpress-inc.).

What email pattern does Clonexpress, Inc. utilize for creating email addresses?

Clonexpress, Inc. employs the email naming pattern '{last}{f}''

What is the geographical location of Clonexpress, Inc.'s headquarters?

Clonexpress, Inc. is headquartered in Gaithersburg, Maryland, US. The precise location is marked by the street address 504 E Diamond Ave.

Blader door bedrijven

Onze bedrijfsindex bevat honderdduizenden bedrijven.